Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31651 - 31675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	FECH	2235	downregulated	Cisplatin results in decreased expression of FECH mRNA	18q21.31	A20427
Cisplatin	Approved Investigational	FGD4	121512	downregulated	Cisplatin results in decreased expression of FGD4 mRNA	12p11.21	A22211
Cisplatin	Approved Investigational	FGFR2	2263	downregulated	Cisplatin results in decreased expression of FGFR2 mRNA	10q26.13	A22211
Cisplatin	Approved Investigational	FGFR3	2261	upregulated	Cisplatin results in increased expression of FGFR3 mRNA	4p16.3	A22251
Cisplatin	Approved Investigational	FHOD3	80206	downregulated	Cisplatin results in decreased expression of FHOD3 mRNA	18q12.2	A22204
Cisplatin	Approved Investigational	FLNB	2317	downregulated	Cisplatin results in decreased expression of FLNB mRNA	3p14.3	A22204
Cisplatin	Approved Investigational	FLVCR2	55640	downregulated	Cisplatin results in decreased expression of FLVCR2 mRNA	14q24.3	A20427
Cisplatin	Approved Investigational	FMNL2	114793	upregulated	Cisplatin results in increased expression of FMNL2 mRNA	2q23.3	A22204
Cisplatin	Approved Investigational	FNBP1	23048	downregulated	Cisplatin results in decreased expression of FNBP1 mRNA	9q34.11	A22205
Cisplatin	Approved Investigational	FNDC3B	64778	downregulated	Cisplatin results in decreased expression of FNDC3B mRNA	3q26.31	A22204
Cisplatin	Approved Investigational	FOCAD	54914	downregulated	Cisplatin results in decreased expression of FOCAD mRNA	9p21.3	A22204
Cisplatin	Approved Investigational	FOSL1	8061	upregulated	Cisplatin results in increased expression of FOSL1 mRNA	11q13.1	A22213 A20427
Cisplatin	Approved Investigational	FOSL2	2355	downregulated	Cisplatin results in decreased expression of FOSL2 mRNA	2p23.2	A20427
Cisplatin	Approved Investigational	FOXC1	2296	upregulated	Cisplatin results in increased expression of FOXC1 mRNA	6p25.3	A22204
Cisplatin	Approved Investigational	FOXF2	2295	upregulated	Cisplatin results in increased expression of FOXF2 mRNA	6p25.3	A22204
Cisplatin	Approved Investigational	FOXJ2	55810	downregulated	Cisplatin results in decreased expression of FOXJ2 mRNA	12p13.31	A21499
Cisplatin	Approved Investigational	FREM2	341640	downregulated	Cisplatin results in decreased expression of FREM2 mRNA	13q13.3	A20427
Cisplatin	Approved Investigational	FRMD4A	55691	downregulated	Cisplatin results in decreased expression of FRMD4A mRNA	10p13	A22204
Cisplatin	Approved Investigational	FSHR	2492	downregulated	Cisplatin results in decreased expression of FSHR mRNA	2p16.3	A22218
Cisplatin	Approved Investigational	FTO	79068	downregulated	Cisplatin results in decreased expression of FTO mRNA	16q12.2	A22204
Cisplatin	Approved Investigational	FUCA1	2517	upregulated	Cisplatin results in increased expression of FUCA1 mRNA	1p36.11	A22204
Cisplatin	Approved Investigational	FUT8	2530	downregulated	Cisplatin results in decreased expression of FUT8 mRNA	14q23.3	A22204
Cisplatin	Approved Investigational	FYN	2534	downregulated	Cisplatin results in decreased expression of FYN mRNA	6q21	A22204
Cisplatin	Approved Investigational	FZD1	8321	downregulated	Cisplatin results in decreased expression of FZD1 mRNA	7q21.13	A21499
Cisplatin	Approved Investigational	GABARAPL1	23710	upregulated	Cisplatin results in increased expression of GABARAPL1 mRNA	12p13.2	A20427

Displaying entries 31651 - 31675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability